Q3 2025 P3 Health Partners Inc Earnings Call Transcript
Key Points
- Capitated revenue increased by approximately 6%, indicating positive growth in revenue streams.
- Operational improvements led to over $100 million in EBITDA improvement year over year.
- A strategic joint venture is expected to add approximately 13,000 fully accreted ACO members, enhancing profitability and cash flow.
- The care enablement model is improving documentation accuracy, quality performance, and care coordination.
- Stable medical cost trends have been maintained, reflecting effective clinical execution and cost management.
- Adjusted EBITDA loss for the quarter was $45.9 million, with a year-to-date loss of $85.2 million.
- Guidance for full-year adjusted EBITDA was revised to a loss range of $110 million to $95 million.
- Mid-year settlement adjustments resulted in a $21 million unfavorable impact on Q3 revenue.
- Challenges remain with non-core assets and specific markets, affecting overall performance.
- There is ongoing pressure to renegotiate contracts and align provider networks to improve margins.
Good day and welcome to the P3 Health 3rd quarter 2025 earnings call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero.
After today's presentation, there will be an opportunity to ask questions.
To ask a question, you may press 1 on a touchtone phone. To withdraw your question, please press 2.
Please note this event is being recorded.
I would now like to turn the call over to Gabby Gable of Investor relations. Please go ahead.
Thank you, operator, and thank you for joining us today. Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under the US Federal securities laws, including statements regarding our financial outlook and long-term target. These forward-looking statements are only predictions and are based largely on our current expectations and projections about future events and financial trends
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
